Full-Time

Senior Director

Patient-Centered Outcomes

Updated on 9/3/2026

Deadline 10/28/27
Lumanity

Lumanity

501-1,000 employees

Healthcare value optimization and access facilitation

Compensation Overview

$150k - $270k/yr

+ Bonus scheme + 401(k) employer match

Remote in USA + 1 more

More locations: Remote in UK

Remote

Remote role; hybrid work is available in the Boston, Massachusetts or Long Beach, California areas.

Bachelor's, Master's, PhD

Category
Consulting (1)

Get referred to Lumanity

See people who can refer or advise you

Requirements
  • An undergraduate degree in a health-related field is required.
  • At least 8 years of previous relevant work experience with increasing levels of responsibility in patient-centered outcomes.
  • Comprehensive knowledge of the drug development process and regulatory guidelines pertaining to patient-centered outcomes.
  • Excellent English oral and written communication skills and comfort liaising with technical and non-technical clients, both internally and externally.
  • Experience in consulting.
  • Published work in peer-reviewed journals and/or presented at conferences.
Responsibilities
  • Apply research to meet clients’ needs, including providing strategic guidance on clinical outcome assessment strategy in the context of drug development.
  • Review project deliverables, including study protocols, study reports, and client presentations, to ensure quality.
  • Support business development efforts by building relationships with new and existing clients, bringing in new leads, and writing proposals for patient-centered outcomes projects.
  • Manage projects as needed, including developing plans to accomplish activities within project scope and timelines, delegating project tasks to project teams, and leading client meetings.
  • Contribute to training and mentoring of more junior staff.
  • Present at scientific conferences and/or publish in peer-reviewed journals to further the patient preference research field and demonstrate the company’s capabilities.
  • Be responsible for an annual business development target.
  • Supervise more junior staff.
Desired Qualifications
  • A master's or doctorate degree in a health-related field.
  • Experience with economic evaluations and health technology assessment submissions, including literature reviews, gap analyses, documenting the humanistic burden of disease, utility elicitation, patient preference studies, and global value dossier development.
  • Mastery of technical skills in at least some of the following areas: expert elicitation, conjoint analysis, contingent valuation, discrete choice experiments, best-worst scaling, time trade-off, and standard gamble methods.

Lumanity helps healthcare brands improve access to medicines by shaping how value is created, demonstrated, and communicated to providers, payers, patients, and regulators. It delivers value-driven strategies across market access, payer and patient communications, and branding to show a medicine’s value clearly. They build data-backed, stakeholder-focused plans that align evidence with payer and patient needs and coordinate cross-functional teams to speed market access. Their goal is to accelerate access to therapies and unlock the full potential of a brand by ensuring its value is understood and adopted in a dynamic healthcare market.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

2022

Get referred to Lumanity

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • MM+M named Lumanity a Top 100 Agency on June 9, 2026.
  • July 7, 2026 SBTi validation strengthens enterprise credibility with sustainability-conscious pharma clients.
  • The Parker Institute, Sorcero, Clarion, and Innovative Edge expand Lumanity's cross-sell surface.

What critics are saying

  • EMULaiTOR and Sorcero face fast commoditization from internal pharma AI teams by 2027.
  • Arsenal Capital ownership pressures exits, forcing aggressive growth targets and potential reorganizations.
  • If AI outputs fail auditability standards, Lumanity loses trust in medical strategy and commercialization.

What makes Lumanity unique

  • Lumanity earned ISO 42001 certification on February 17, 2026, for responsible AI.
  • EMULaiTOR launched February 24, 2026, with purpose-built synthetic personas for life sciences.
  • The May 28, 2025 Parker Institute alliance embeds Lumanity inside cancer translation workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Flexible Work Hours

Hybrid Work Options

Commuter Benefits

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Employee Assistance Program

Life Insurance

Wellness Program

Professional Development Budget

Company News

PharmiWeb
May 29th, 2025
Lumanity And The Parker Institute Join Forces To Accelerate Immunotherapy Innovation

New strategic alliance brings expert insight and support to help translate scientific breakthroughs into patient impact. Boston, MA and San Franciso, CA, 08:00 ET May 28, 2025 – Lumanity, a global life sciences strategic services partner, and the Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts, today announced a strategic alliance aimed at accelerating next-generation cancer immunotherapies. By combining PICI’s translational research engine with Lumanity’s development and commercialization expertise, the partnership is designed to ensure that promising scientific breakthroughs reach patients more effectively

Zenopa
Mar 25th, 2024
Lumanity and Sorcero Unveil Collaboration for AI-Centered Medical Strategy

Sorcero, a company that specialises in building AI-powered language intelligence platforms for various industries, including healthcare, life sciences, and insurance, has partnered with Lumanity to provide AI-centered strategy services.

Lumanity
Sep 20th, 2023
Stripe Communications a Finalist in The Herald & GenAnalytics 2023 Diversity Awards Scotland

Stripe Communications a finalist in the Herald & GenAnalytics 2023 Diversity Awards Scotland.

PHARMO Institute
Jul 31st, 2023
News

PHARMO Institute for Drug Outcomes Research is pleased to announce its partnership with Lumanity, an organization dedicated to accelerating and optimizing access to medical advances.

Clarion Healthcare
Nov 24th, 2022
Lumanity Expands U.S. Life Sciences Consulting Capability with the Acquisition of Clarion - Clarion

Lumanity expands US life sciences consulting with acquisition of Clarion. Lumanity and Clarion will work together to bring services to bio-pharma clients.